# Vincent Rajkumar
Top-podcastafleveringen
Bijgewerkt:
Top podcast episodes featuring vincent rajkumar.
Episode 37: What is Myeloma and What is Not?
Dr. Vincent Rajkumar of the Mayo Clinic visits the Healthcare Unfiltered EXPRESS to review published data on what constitutes myeloma on the molecular and genomic level. Turns out that some patients that we thought do not have myeloma, they indeed have the disease. A must listen and a provocative e…
FDA Approval of Daratumumab in High Risk Smoldering Myeloma: AQUILA by Dr. Vincent Rajkumar
In this episode of the Oncology Brothers podcast, we dived into the recent FDA approval of daratumumab for high-risk smoldering myeloma, based on the groundbreaking AQUILA study. We were joined by Dr. Vincent Rajkumar, a world-renowned myeloma specialist, who provided valuable insights into the com…
Mayo Clinic Proceedings: Stories that Changed the World
For a century, Mayo Clinic Proceedings has captured the evolution of modern medicine, from pioneering cortisone therapy to today’s breakthroughs in artificial intelligence and digital diagnostics. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with Editor in Chief Dr. …
Episode 50: The MajesTEC-3 Trial in Myeloma
Dr. Vincent Rajkumar of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to highlight a major study recently published in the NEJM concerning patients with R/R multiple myeloma. This study is arguably changing the standard of care for relapsed disease. We discussed the study, its rationale, …
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
Dr. Monty Pal speaks with internationally acclaimed hematologists Dr. Vincent Rajkumar and Dr. Saad Usmani about the AQUILA trial in high-risk smoldering multiple myeloma, as well as advances in CAR-T and other evolving treatment strategies in the myeloma space.
TRANSCRIPT
Dr. Monty Pal: Hello …
Episode 71. Management of Newly Diagnosed Multiple Myeloma with Dr. Vincent Rajkumar
In this episode, Raj, Ashwin, and Eddie sit down with Dr. Vincent Rajkumar — Professor of Medicine at Mayo Clinic and Chair of the ECOG Myeloma Committee — for a clinically focused conversation on newly diagnosed multiple myeloma. Topics span baseline workup, risk stratification, induction selectio…
Evolving Treatment Landscape of Multiple Myeloma: Bispecifics, CAR T, and CELMoDs
We dived deep into the rapidly evolving landscape of second-line and beyond treatment options for multiple myeloma. In this episode, we were joined by esteemed experts Beth Faiman, PhD, CNP, Vincent Rajkumar, MD, and Rafael Fonseca, MD, who shared their insights on the latest advancements in bispec…
Episode 58: The ENDURANCE (E1A11) Myeloma Trial in NEJM
Hot off the press, the ENDURANCE trial was JUST published in NEJM. This trial explored whether patients with newly diagnosed myeloma benefit from long-term maintenance lenalidomide versus 2-years only. Dr. Vincent Rajkumar, senior author on the paper, shares the findings and context. Please subscri…
ENDURANCE Trial - Time-limited Lenalidomide Maintenance for Standard Risk Myeloma
Welcome to the Oncology Brothers podcast! In this episode, we dived into the latest advancements in multiple myeloma treatment, focusing on the practice changing ENDURANCE trial. Joined by esteemed guests Dr. Shaji Kumar and Dr. Vincent Rajkumar from Mayo Clinic, they discussed the new time limited…
Episode 292 - CELMoDs in Myeloma: A Report From EHA
Chadi is joined by two of the world's leading multiple myeloma experts, Dr. Sagar Lonial of Emory University and Dr. Vincent Rajkumar of Mayo Clinic, for an in-depth discussion of the latest advances in multiple myeloma presented at the European Hematology Association (EHA) Congress in Stockholm. T…
PODCAST-ZOEKMACHINE
U kunt onze website gebruiken om3,828,634podcasts en196,452,518afleveringen te zoeken op mensen, plaatsen of onderwerpen.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
